Immunex/Genentech Create Fusion With Enbrel License, Cancer Deals
Recent deals between Immunex and Genentech demonstrate a new level of collaboration between the biotech firms.
You may also be interested in...
Amgen will file a BLA for rheumatoid arthritis therapy IL-1ra in the fourth quarter without conducting Phase III trials.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011